Bianco R - Search Results

1

Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.

Di Lorenzo G, Autorino R, De Laurentiis M, Bianco R, Lauria R, Giordano A, De Sio M, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Among authors: bianco ar, bianco r. Tumori. 2003 Jul-Aug;89(4):349-60. doi: 10.1177/030089160308900402. Tumori. 2003. PMID: 14606635 Review.

2

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

Bianco C, Tortora G, Bianco R, Caputo R, Veneziani BM, Caputo R, Damiano V, Troiani T, Fontanini G, Raben D, Pepe S, Bianco AR, Ciardiello F. Bianco C, et al. Among authors: bianco ar, bianco r. Clin Cancer Res. 2002 Oct;8(10):3250-8. Clin Cancer Res. 2002. PMID: 12374696

3

Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.

Tortora G, Caputo R, Damiano V, Melisi D, Bianco R, Fontanini G, Veneziani BM, De Placido S, Bianco AR, Ciardiello F. Tortora G, et al. Among authors: bianco ar, bianco r. Clin Cancer Res. 2003 Apr;9(4):1566-72. Clin Cancer Res. 2003. PMID: 12684433

4

Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.

Ciardiello F, Bianco R, Caputo R, Caputo R, Damiano V, Troiani T, Melisi D, De Vita F, De Placido S, Bianco AR, Tortora G. Ciardiello F, et al. Among authors: bianco ar, bianco r. Clin Cancer Res. 2004 Jan 15;10(2):784-93. doi: 10.1158/1078-0432.ccr-1100-03. Clin Cancer Res. 2004. PMID: 14760102

5

Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.

Bianco R, Caputo R, Caputo R, Damiano V, De Placido S, Ficorella C, Agrawal S, Bianco AR, Ciardiello F, Tortora G. Bianco R, et al. Among authors: bianco ar. Clin Cancer Res. 2004 Jul 15;10(14):4858-64. doi: 10.1158/1078-0432.CCR-03-0497. Clin Cancer Res. 2004. PMID: 15269162

6

Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.

Raben D, Bianco C, Damiano V, Bianco R, Melisi D, Mignogna C, D'Armiento FP, Cionini L, Bianco AR, Tortora G, Ciardiello F, Bunn P. Raben D, et al. Among authors: bianco ar, bianco r, bianco c. Mol Cancer Ther. 2004 Aug;3(8):977-83. Mol Cancer Ther. 2004. PMID: 15299080

7

Ovarian luteinized thecoma with sclerosing peritonitis in an adult woman treated with leuprolide and toremifene in complete remission at 5 years.

Bianco R, de Rosa G, Staibano S, Somma P, Bianco AR. Bianco R, et al. Among authors: bianco ar. Gynecol Oncol. 2005 Mar;96(3):846-9. doi: 10.1016/j.ygyno.2004.10.044. Gynecol Oncol. 2005. PMID: 15721435

8

Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.

Damiano V, Melisi D, Bianco C, Raben D, Caputo R, Fontanini G, Bianco R, Ryan A, Bianco AR, De Placido S, Ciardiello F, Tortora G. Damiano V, et al. Among authors: bianco ar, bianco r, bianco c. Clin Cancer Res. 2005 Aug 1;11(15):5639-44. doi: 10.1158/1078-0432.CCR-05-0174. Clin Cancer Res. 2005. PMID: 16061883

9

Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.

Melisi D, Caputo R, Damiano V, Bianco R, Veneziani BM, Bianco AR, De Placido S, Ciardiello F, Tortora G. Melisi D, et al. Among authors: bianco ar, bianco r. Endocr Relat Cancer. 2005 Dec;12(4):1051-8. doi: 10.1677/erc.1.01061. Endocr Relat Cancer. 2005. PMID: 16322342

10

Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.

Damiano V, Caputo R, Bianco R, D'Armiento FP, Leonardi A, De Placido S, Bianco AR, Agrawal S, Ciardiello F, Tortora G. Damiano V, et al. Among authors: bianco ar, bianco r. Clin Cancer Res. 2006 Jan 15;12(2):577-83. doi: 10.1158/1078-0432.CCR-05-1943. Clin Cancer Res. 2006. PMID: 16428503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

589 results

Search Page

Filters